Transforming Healthcare with Deep Data, Microsampling and Wearables

Michael P. Snyder, Stanford Medicine will follow the weekly updates in the BIONews.

Despite wearables existing for a long time, their potential benefits for human health have yet to be fully explored. Whether measured in blood, motion, or environment, each person’s health is unique and changes over time. Imagine a future where you can receive a text message to take an at-home test and then get the results shot right over to your primary care physician. Or you can wear a health tracker that can detect an infectious disease, anemia, or even type II diabetes and cancer before noticing them as symptoms and seeking medical care.

Join Dr. Michael Snyder to learn about the latest research on individualized medicine and how real-time health monitoring and the power of long-term, deep data on individual patients can save lives. Mike Snyder, Stanford W. Ascherman Professor of Genetics Professor Snyder is a leader in the field of functional genomics and proteomics, and one of the major participants of the ENCODE project. He combined different state-of-the-art “omics” technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of a person and used this to assess disease risk and monitor disease states for personalized medicine. He and his lab were the first to perform a large-scale functional genomics project in any organism and has developed many technologies in genomics and proteomics.

Event Information

Event Topic:
Join us for our weekly BIONews Update and a current video

Event Description:

Date/Time:
Date(s) - 03/07/23
8:15 am - 10:30 am

Event Location:
Zoom talk: https://us02web.zoom.us/j/88573518331:

Speaker Information

Event Speaker:
Harry Wachob

Event Speaker Title:
Founder & President

Event Speaker Company:
Bio2Device Group

Event Speaker Bio:

Harry Wachob is the Founder and President of the Bio2Device Group. He is an experienced engineering leader in materials science, biomedical device engineering and R&D. He has directed and mentored multidisciplinary teams in solving complex technical issues in order to improve the safety, reliability, and performance of medical devices. Most recently, he was the Managing Materials Scientist at Xoft. Previously he was Director of Engineering for Aerogen, a biopharmaceutical company specializing in novel aerosol drug delivery. Prior to that, Harry was Managing Engineer at Exponent/Failure Analysis Associates where he guided research and development, and product failure investigations covering a broad range of medical and industrial applications. He received his engineering degrees in Materials Science & Engineering from Cornell University.

Event Details

Cost:
$0

Add To Calendar